Next Article in Journal
Differences in Motor Development between Preterm Infants and Full-Term Preschool Children
Next Article in Special Issue
Pre-Admission Oral Clonidine to Reduce Severe Pre-Operative Anxiety in Pediatric Patients with Behavioral Disorders: A Case Series
Previous Article in Journal
Diet and Lipid-Lowering Nutraceuticals in Pediatric Patients with Familial Hypercholesterolemia
Previous Article in Special Issue
Ultrasound-Guided Occipital Nerve Blocks as Part of Multi-Modal Perioperative Analgesia in Pediatric Posterior Craniotomies: A Case Series
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Safety Assessment of Prolonged Nerve Catheters in Pediatric Trauma Patients: A Case Series Study

Children’s Hospital of Pittsburgh, University of Pittsburgh Medical Center, 4401 Penn Ave., Pittsburgh, PA 15224, USA
*
Author to whom correspondence should be addressed.
Children 2024, 11(2), 251; https://doi.org/10.3390/children11020251
Submission received: 29 January 2024 / Revised: 5 February 2024 / Accepted: 14 February 2024 / Published: 16 February 2024
(This article belongs to the Special Issue State-of-Art in Pediatric Anesthesia)

Abstract

:
Introduction: Nerve block catheters (NBCs) are increasingly used for pain management in pediatric trauma patients. While short-term efficacy has been well established, the long-term safety of NBCs is unknown. Methods/Cases: The retrospective chart review includes a cohort of nine pediatric trauma patients aged 3–15 years who received 52 peripheral nerve block catheters and epidurals for pain management. This study aimed to investigate the potential risks associated with the prolonged use of NBCs in pediatric trauma cases. Results: The NBCs (48 peripheral catheters and 4 epidural catheters) were maintained for about 2 weeks. The number of catheters per patient varied from 1 to 11. The study noted a low frequency of catheter-related complications. No catheter-site infection or local anesthetic toxicity symptoms were reported. Discussion: These findings suggest that NBCs can be safely maintained for extended periods in pediatric trauma patients without significantly increasing complications. Careful monitoring and adherence to infection control practices remain paramount when implementing extended catheter use.

1. Introduction

Pain control in children is critical since undertreated pain can lead to long-term medical and psychiatric consequences [1]. One way to manage pain in the trauma patient is regional anesthesia. However, many trauma patients require repeated surgeries, and pain control remains an issue for weeks. Risks with performing prolonged regional anesthesia catheters include the risk of infection, local anesthetic toxicity, and nerve injury. Walker and colleagues did not find any incidence of local anesthetic toxicity or prolonged nerve injury in pediatric patients who received peripheral nerve catheters [2].
In a study of 2074 pediatric patients with peripheral nerve catheters, Walker and colleagues found an infection rate of 0.9%. The only significant predictor of infection these authors found was catheter duration: a median (IQR) of 4.5 days (3–7) for infected catheters compared to 3 (1–3) days for non-infected catheters [2]. It is standard to remove peripheral nerve catheters after 48–72 h (about 3 days) since data show the infection rate increases at this duration, although infection is still rare [3,4,5,6]. However, in certain situations, longer catheter durations have been reported, including trauma and cancer patients. There is a case report of a pediatric trauma patient having a popliteal nerve catheter for 46 days (about 1 and a half months) [7]. Another case series reported placing continuous nerve catheters for 22–36 days (about 1 month 5 and a half days) in four different patients for pathologic fractures due to cancer pain [8]. Another case report describes a continuous popliteal catheter for 68 days (about 2 months 1 week) in a military combat-related polytrauma requiring multiple orthopedic surgeries [9].
Infection in continuous peripheral nerve blocks is, fortunately, a rare event. It has been reported that colonization of the catheter tip with skin microbes is common, with rates up to 50% [3,10,11]. However, the risk of infection leading to abscess formation or requiring antibiotics is low, around 0–3.2% [11,12,13]. The most common sites of infection are femoral and axillary catheter site insertions, but interscalene insertions also have case reports of severe infection [11,12,13,14]. Use of prophylactic antibiotics, site of insertion, aseptic technique, and catheter duration have all been shown to influence the risk of severe infection, while tunneling and the use of bio patch have not been studied and remain controversial [12,14,15,16].
We present a case series of nine pediatric trauma patients who received 52 continuous peripheral nerve and epidural catheters for up to 15 days (about 2 weeks) with no infectious complications requiring additional treatment.

2. Cases and Results

The University of Pittsburgh’s Institutional Review Board approved the study, Study number 23050074, on 28 June 2023. Informed consent was waived due to a HIPAA authorization form being signed, and it is also included in anesthesia consent, and all data was deidentified. The ages of the nine patients in this retrospective study ranged from 3 to 12 years. Their injury complex had degloving injuries, avulsions, traumatic amputations, and one case of limb necrosis from thrombosis after extracorporeal mechanical support. The patients were all brought to the operating room for repeated irrigation and debridements, wound vacuum placement and changes, and skin grafting surgeries. Inclusion criteria were pediatric patients that had traumatic injuries requiring multiple operations within the time frame of the study. Patients were excluded if they did not receive any nerve block catheter for longer than 72 h. Demographic data is shown in Table 1.
All patients had more than one catheter placement and up to four catheters per block location. There were 52 total catheters in the nine patients, 48 were peripheral catheters, and four were epidural catheters. The range of duration of each catheter placement was 2–15 days (about 2 weeks), and each patient had between one and 11 catheters placed. Three patients had bilateral catheters placed at the same time. The range of durations of total catheters per patient was 7–33 days (about 1 month).
All the patients had clonidine 1–2 mcg/mL and 0.2% ropivacaine in their peripheral nerve block solution, with no evidence of toxicity or side effects from local anesthetic or clonidine. Infusions were run at 0.5 mg/kg/h, and bags were usually changed when the infusions completed, which was once every 1–2 days. All patients received antibiotics before surgery as prophylaxis, and most were on scheduled antibiotics for the duration of the nerve block catheter insertion due to their traumatic injury. The dressings of 24% of catheters included a chlorhexidine gluconate-impregnated disc (Biopatch®, Ethicon, Inc., Somerville, NJ, USA), and 5% of the catheters were tunneled. No patients had a nerve block catheter-related infection, although several patients had leukocytosis and fever during the time the catheters were indwelling. No patients had local anesthetic complications. No additional treatment was needed for nerve block-related complications. All blocks were placed under general anesthesia when the patients returned to the operating room for debridement and wound vacuum changes. Data is shown in Table 2.
Catheter-related complications included leaking (4), dislodgement (2), dressing contamination (5), erythema (1), and disconnection (1), but none of these complications resulted in an infection at the catheter site.
Patient #1 received two right-sided popliteal catheters for 11 days (about 1 and a half weeks) each and one epidural for 7 days. The first popliteal catheter was replaced on day 11 due to leaking and replaced with a tunneled popliteal catheter. An epidural was later placed for free flap definitive surgery, and the patient was no longer on scheduled antibiotics at that point. There were no nerve block-related complications or infections.
Patient #2 received four right femoral nerve block catheters for 11, 8, 4, and 10 days (about 1 and a half weeks). The patient received two right popliteal and one right sciatic catheter for 11, 10, and 12 days (about 1 week 5 days), respectively. They had two epidurals that were in place for 8 and 6 days, respectively, where the second catheter was tunneled. During treatment, the patient’s antibiotics were completed, and there was a period when the patient was not on antibiotics. The antibiotic treatment was restarted due to leukocytosis several days later. There were no fevers, and the patient was found to be positive for clostridium difficile. One of the patient’s popliteal catheters had to be redressed due to excoriation and peeling of the dressing, but the catheter insertion site was clean, dry, and intact.
Patient #3 had three right popliteal catheters and three left popliteal catheters for 3, 8, and 7 days, respectively. These were present simultaneously. They subsequently received two bilateral sciatic catheters for 13 and 10 days (about 1 and a half weeks). The patient had an epidural placed for definitive free flap surgery, which was left in place for 8 days and was tunneled. The second left sciatic catheter was leaking on day five and was redressed. The epidural site had redness on day six and was redressed. There was no concern for site infection or abscess.
Patient #4 had right-sided upper extremity catheters placed, including two supraclavicular catheters and two infraclavicular catheters left in place for 7, 3, 7, and 2 days, respectively. The second supraclavicular catheter was removed early due to leaking and loose dressing, and the second infraclavicular catheter was removed early for the same reason. No infections were noted. This patient had a fever during the second supraclavicular catheter, but the nerve block was not suspected to be the source.
Patient #5 received a left popliteal continuous nerve catheter for 11 days (about 1 and a half weeks) with no complications noted.
Patient #6 received three right popliteal catheters for 3, 6, and 9 days, respectively, and two left popliteal catheters for 11 and 9 days, respectively. These were present simultaneously. One of the right catheters was removed accidentally, one was removed due to an unwitnessed disconnect, and one was removed because of fevers. The nerve block sites were clean, with no signs of infection or abscess.
Patient #7 received four right femoral catheters for 3, 15, 2, and 3 days, four right sciatic catheters for 3, 7, 13, and 5 days, two right lumbar plexus catheters for 2 and 3 days, and one right popliteal catheter for 9 days. The right popliteal catheter had a Biopatch placed. This patient had catheter replacements several times due to urine and stool contamination of the catheter dressings. The patient was febrile due to a wound infection but no known nerve catheter-related infections.
Patient #8 received bilateral supraclavicular catheters twice due to necrosis and thrombosis of her limbs after an invasive infection. These were left in for 14 days (about 2 weeks) initially. The second right catheter was in place for 7 days, while the left was removed accidentally after 4 days. While she had wound infections, there were no nerve catheter infections.
Patient #9 received one left sciatic catheter for 9 days, two left femoral catheters for 9 and 3 days, and one left popliteal catheter for 11 days (about 1 and a half weeks). The sciatic catheter dressing was contaminated by stool, so it was removed to prevent site infection. The popliteal catheter had a disconnect and leaking around the dressing, so it was preemptively removed.

3. Discussion

In the pediatric population, reducing opioids and opioid-related complications, reducing parental and caregiver stress, and reducing the risk of chronic pain is essential. A multimodal approach, including regional anesthesia, is critical to achieving these goals [17,18].
Minimal data has been published on the safety of maintaining long-term peripheral nerve and epidural catheters, and standard recommendations are to remove them after 48–72 h (about 3 days) [2,6,10]. This is based on data where the risk of infection is around 0.9% and starts to increase after 72 h (about 3 days) [2], although no specific cases of systemic infection or abscess are reported. In simple surgical patients, this may be the best recommendation. However, this may not be beneficial in certain situations when patients require multiple surgeries with a prolonged course. The current study revealed that prolonged peripheral nerve catheters can be considered in specific pediatric trauma cases where pain control remains a challenge. Despite prolonged catheter use, the infection rate remained low, with no catheter-related infections or infections at the insertion site. This is comparable to a similar case report of a pediatric trauma patient who maintained a peripheral nerve catheter for 46 days (about 1 and a half months) [7].
Despite prolonged catheter use, the infection rate remained low, in line with established infection prevention protocols. We had zero catheter-related infections or insertion site infections, which is lower than the rate published in the literature of 0.9% [2]. This reinforces the importance of maintaining strict aseptic techniques when managing PNCs. Our practice is to check the dressings for PNCs daily and monitor temperature and laboratory results. All nine of our patients were on antibiotics for most of the duration of the nerve block. In the available literature, antibiotics reduce the incidence of infection, and antibiotics are the treatment for catheter-related infections [14,15,16]. Additionally, we used an antimicrobial adjuvant in 24% of our catheter dressings (Biopatch®, Ethicon, Inc., Somerville, NJ, USA). See Figure 1 and Figure 2 for a detailed representation of the dressing techniques used in these cases. Although controversial, this is another method to reduce infections that was not used in any severe infection cases we reviewed in the literature. The Biopatch has been used in adult patients to minimize the infection rate of epidural catheters and in pediatric and adult patients to reduce the risk of infection of central venous catheters [19,20]. There is another securement dressing option that contains chlorhexidine gluconate and is transparent to allow visibility of the insertion site, called Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M TegadermTM) (Figure 3). This device has also been used to reduce the risk of infection of indwelling catheters [21]. However, we did not use it in our patient population, and more studies need to be done to investigate the complication rates with this dressing technique. In addition to checking dressings, using antibiotics, and using a Biopatch, we also changed the dressing when it was contaminated and replaced and rotated sites for peripheral nerve catheters.
Suppose nerve block catheters are placed with a strict aseptic technique, the site is tunneled or dressed with an antimicrobial dressing, and the site is monitored daily for infection. In that case, we believe it is safe to prolong the duration of these catheters for pediatric patients undergoing multiple surgeries. The risks of catheter site infection are also mitigated by monitoring the patient for fever and other systemic signs of infection and by having the patient on systemic antibiotics.
We observed no infection and a low frequency of complications such as dressing contamination, catheter disconnect, and dislodgment. This suggests that long-term nerve block catheters can be considered for pain management in this patient population. The pediatric trauma patient population is at high risk for developing chronic pain after their injuries. We believe that our techniques and methods to reduce infection lead to a safe, beneficial pain management strategy that outweighs the risk of infectious related complications. We believe this will help pediatric trauma patients avoid the risk of chronic pain. We also believe that it will help avoid systemic opioids, which lead to many undesirable side effects, such as addiction, tolerance, dependence, constipation, and respiratory depression [17].
However, it is essential to acknowledge the limitations of this case series study. The sample size was small, and the results may not be generalizable to all pediatric trauma patients. Further research with larger sample sizes and randomized controlled trials would be valuable in confirming and expanding upon our findings.
In conclusion, our study provides evidence that a wide variety of nerve block catheters can be maintained for up to 15 days (about 2 weeks) without an increased risk of infection or local anesthetic toxicity if strict aseptic technique is used with daily monitoring of the site.
The knowledge gained from this research can help pain doctors make decisions regarding maintaining these catheters for longer than 72 h (about 3 days). It can improve the quality of care for pediatric trauma patients that will have multiple surgeries and remain hospitalized for longer time frames.

Author Contributions

N.V. worked on idea conceptualization, data collection, writing, editing, analysis, and revising; A.P. worked on editing and writing; M.V. worked on advising, editing, writing, and revising. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The University of Pittsburgh Institutional Review Board approved this study (STUDY23050074) on 28/06/2023.

Informed Consent Statement

Informed consent was waived by the University of Pittsburgh Institutional Review Board since all data is completely de-identified.

Data Availability Statement

Data is unavailable due to privacy or ethical restrictions.

Conflicts of Interest

There are no conflicts of interest to disclose.

References

  1. Pardesi, O.; Fuzaylov, G. Pain management in pediatric burn patients: Review of recent literature and further directions. J. Burn Care Res. 2017, 38, 335–347. [Google Scholar] [CrossRef] [PubMed]
  2. Walker, B.; Long, J.; De Oliveira, G.; Szmuk, P.; Setiawan, C.; Polaner, D.; Suresh, S.; the PRAN (Pediatric Regional Anesthesia Network) Investigators. Peripheral nerve catheters in children: An analysis of safety and practice patterns from the pediatric regional anesthesia network (PRAN). Br. J. Anaesth. 2015, 115, 457–462. [Google Scholar] [CrossRef] [PubMed]
  3. Jeng, C.L.; Torrillo, T.M.; Rosenblatt, M.A. Complications of peripheral nerve blocks. Br. J. Anaesth. 2010, 105, i97–i107. [Google Scholar] [CrossRef] [PubMed]
  4. Gurnaney, H.; Kraemer, F.W.; Maxwell, L.; Muhly, W.T.; Schleelein, L.; Ganesh, A. Ambulatory continuous peripheral nerve blocks in children and adolescents: A longitudinal 8-year single center study. Anesth. Analg. 2014, 118, 621–627. [Google Scholar] [CrossRef] [PubMed]
  5. Ganesh, A.; Rose, J.B.; Wells, L.; Ganley, T.; Gurnaney, H.; Maxwell, L.G.; DiMaggio, T.; Milovcich, K.; Scollon, M.; Feldman, J.M.; et al. Continuous Peripheral Nerve Blockade for Inpatient and Outpatient Postoperative Analgesia in Children. Anesth. Analg. 2007, 105, 1234–1242. [Google Scholar] [CrossRef] [PubMed]
  6. Visoiu, M.; Joy, L.N.; Grudziak, J.S.; Chelly, J.E. The effectiveness of ambulatory continuous peripheral nerve blocks for postoperative pain management in children and adolescents. Pediatr. Anesthesia 2014, 24, 1141–1148. [Google Scholar] [CrossRef] [PubMed]
  7. Hertz, L.; Sola, C.; De La Arena, P.; Dadure, C. Acute Pain Management in a Child: A Case Report of 46-Days of Popliteal Sciatic Nerve Catheter. Int. J. Anesth. Anesthesiol. 2018, 5, 063. [Google Scholar] [CrossRef]
  8. Burgoyne, L.; Pereiras, L.; Bertani, L.; Kaddoum, R.; Neel, M.; Faughnan, L.; Anghelescu, D. Long-term use of nerve block catheters in pediatric patients with cancer related pathologic fractures. Anaesth. Intensive Care 2012, 40, 710–713. [Google Scholar] [CrossRef] [PubMed]
  9. Fontana, C.; Rocco, M.; Vetrugno, L.; Bignami, E. Long-term placement of continuous popliteal nerve block catheter for management of a wounded patient in a combat field environment: A case report. Local Reg. Anesthesia 2019, 12, 67–70. [Google Scholar] [CrossRef] [PubMed]
  10. Ilfeld, B. Continuous peripheral nerve blocks: A review of the published evidence. Anesth. Analg. 2011, 113, 904–925. [Google Scholar] [CrossRef] [PubMed]
  11. Cuvillon, P.; Ripart, J.; Lalourcey, L.; Veyrat, E.; L’hermite, J.; Boisson, C.; Thouabtia, E.; Eledjam, J.J. The Continuous Femoral Nerve Block Catheter for Postoperative Analgesia: Bacterial Colonization, Infectious Rate and Adverse Effects. Anesth. Analg. 2001, 93, 1045–1049. [Google Scholar] [CrossRef] [PubMed]
  12. Jeng, C.; Rosenblatt, M. Overview of Peripheral Nerve Blocks. May 2023. Available online: Uptodate.com (accessed on 11 May 2023).
  13. Neuburger, M.; Buttner, J.; Blumenthal, S.; Breitbarth, J.; Borgeat, A. Inflammation and infection complications of 2285 perineural catheters: A prospective study. Acta Anaesthesiol. Scand. 2007, 51, 108–114. [Google Scholar] [CrossRef] [PubMed]
  14. Capdevila, X.; Brinquier, S.; Borgeat, A. Infectious risk of continuous peripheral nerve blocks. Anesthesiology 2009, 110, 182–188. [Google Scholar] [CrossRef] [PubMed]
  15. Hebl, J.R. The importance and implications of aseptic techniques during regional anesthesia. Reg. Anesth. Pain Med. 2006, 31, 311–323. [Google Scholar] [CrossRef] [PubMed]
  16. Morin, A.M.; Kerwat, K.M.; Klotz, M.; Niestolik, R.; Ruf, V.E.; Wulf, H.; Zimmermann, S.; Eberhart, L.H. Risk factors for bacterial catheter colonization in regional anesthesia. BMC Anesthesiol. 2005, 5, 1. [Google Scholar] [CrossRef] [PubMed]
  17. Ferland, C.; Vega, E.; Ingelmo, P. Acute pain management in children: Challenges and recent improvements. Curr. Opin. Anesthesiol. 2010, 31, 327–332. [Google Scholar] [CrossRef] [PubMed]
  18. Suresh, S.; Birmingham, P.; Kozlowski, R. Pediatric pain management. Anesthesiol. Clin. 2012, 30, 101–117. [Google Scholar] [CrossRef] [PubMed]
  19. Mann, T.J.; Orlikowski, C.E.; Gurrin, L.C.; Keil, A.D. The Effect of the Biopatch, a Chlorhexidine Impregnated Dressing, on Bacterial Colonization of Epidural Catheter Exit Sites. Anaesth. Intensive Care 2001, 29, 600–603. [Google Scholar] [CrossRef] [PubMed]
  20. Ho, K.M.; Litton, E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: A metanalysis. J. Antimicrob. Chemother. 2006, 58, 281–287. [Google Scholar] [CrossRef] [PubMed]
  21. Jeanes, A.; Bitmead, J. Reducing bloodstream infection with a chlorhexidine gel IV dressing. Br. J. Nurs. 2015, 24, S14–S19. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) The initial dressing of the catheter was surgical skin glue at the insertion site, liquid medical adhesive surrounding the catheter, and the Biopatch on top of the insertion site. Strips of medical tape are then placed on top of the Biopatch. (B) Finished dressing, with a transparent catheter securement dressing on top of the steri strips, Biopatch, and catheter, followed by transparent dressings. Finally, the dressing is labeled with the site.
Figure 1. (A) The initial dressing of the catheter was surgical skin glue at the insertion site, liquid medical adhesive surrounding the catheter, and the Biopatch on top of the insertion site. Strips of medical tape are then placed on top of the Biopatch. (B) Finished dressing, with a transparent catheter securement dressing on top of the steri strips, Biopatch, and catheter, followed by transparent dressings. Finally, the dressing is labeled with the site.
Children 11 00251 g001
Figure 2. (A) This is the first steps of securing the catheter, including surgical skin glue at the insertion site, liquid medical adhesive surrounding the catheter, and the Biopatch on top of the insertion site. Strips of medical tape are then placed on top of the Biopatch. (B) Finished dressing, with a transparent catheter securement dressing on top of the steri strips, Biopatch, and catheter, followed by transparent dressings. Finally, the dressing is labeled with the site.
Figure 2. (A) This is the first steps of securing the catheter, including surgical skin glue at the insertion site, liquid medical adhesive surrounding the catheter, and the Biopatch on top of the insertion site. Strips of medical tape are then placed on top of the Biopatch. (B) Finished dressing, with a transparent catheter securement dressing on top of the steri strips, Biopatch, and catheter, followed by transparent dressings. Finally, the dressing is labeled with the site.
Children 11 00251 g002
Figure 3. Securement dressing option that contains chlorhexidine gluconate and is transparent to allow visibility of the insertion site, called Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M TegadermTM).
Figure 3. Securement dressing option that contains chlorhexidine gluconate and is transparent to allow visibility of the insertion site, called Tegaderm CHG Chlorhexidine Gluconate IV Securement Dressing (3M TegadermTM).
Children 11 00251 g003
Table 1. Demographic data of patients receiving prolonged continuous nerve block catheters.
Table 1. Demographic data of patients receiving prolonged continuous nerve block catheters.
Patient #Age (Year)Weight (kg)ASA * ClassInjurySurgeries
18362Degloving of right lateral footRepeated irrigation, debridement, wound vacuum changes, and free flap skin graft surgery.
24242Lawnmower injury to right lower extremityRepeated irrigation, debridement, wound vacuum changes, and free flap skin graft surgery.
33202Degloving injury from a lawnmower to bilateral lower extremitiesRepeated irrigation and debridement, wound vacuum changes
43183Right upper extremity amputation from lawnmowerIrrigation and debridement, wound vacuum placement, complete amputation
512521Dirt bike injury causing left lower extremity avulsionIrrigation and debridement
66221Bilateral trans metatarsal amputations from lawnmower injuryRepeated irrigation and debridement, wound vacuum placement, and changes
74143Lawnmower induced right lower extremity fractures, lacerations, degloving injuryOpen reduction and internal fixation, exploration of wound, wound vacuum placement, and changes
86213Septic shock leading to extra-corporeal membrane support, complicated with thromboses to bilateral upper extremitiesIrrigation and debridement to bilateral upper extremity, skin grafting
94182Partial amputation from lawn mower to left lower extremity Left foot irrigation and debridement, wound vacuum changes
* ASA (American Society of Anesthesiologists) class refers to the Anesthesiology physical classification I–VI. ASA I refers to a normal healthy patient. ASA II refers to mild systemic disease. ASA III refers to severe systemic disease. ASA IV refers to systemic disease that is a constant threat to life. ASA V refers to a patient who is not expected to survive without surgery. ASA VI is a declared brain-dead patient for organ donation.
Table 2. The duration, location, and related data for nine patients receiving continuous peripheral nerve catheters. Each catheter is listed, with multiple catheters placed per patient #. There were no incidences of local anesthetic-related complications. No interventions were noted for any catheter-related complications. Normal white blood cell count is 5–17 × 109/L.
Table 2. The duration, location, and related data for nine patients receiving continuous peripheral nerve catheters. Each catheter is listed, with multiple catheters placed per patient #. There were no incidences of local anesthetic-related complications. No interventions were noted for any catheter-related complications. Normal white blood cell count is 5–17 × 109/L.
Patient #Nerve Block Location# of CathetersDuration of Catheters IndividuallyTotal Number of Days with a Catheter in PlaceOperating Room AntibioticsScheduled AntibioticsBio Patch UsedTunneled CatheterCatheter ComplicationsFeversInfections
1Right popliteal211, 1122YesYesNot noted#2Leaking day 11 of the first catheterNoNo
1Epidural177YesNoNot notedNot notedNoneNoNo
2Right femoral411, 8, 4, 1033YesYesNot notedNot notedNoneNoLeukocytosis
2Right popliteal211, 1021YesYes *Not notedNot notedExcoriation and peeling up from dressing on day 6NoLeukocytosis
2Right anterior sciatic11212YesNo, but it started during the catheterNot notedNot notedNoneNoLeukocytosis
2Epidural28, 614YesYesNot noted#1NoneNoPositive for Clostridium Difficile
3Right popliteal33, 8, 7 YesYesNot notedNot notedNoneNoNo
3Left popliteal33, 8, 7 YesYesNot notedNot notedNoneNoNo
3Right sciatic213, 1023YesYesNot notedNot notedNoneNoNo
3Left sciatic213, 1023YesYesNot notedNot notedLeaking of the second sciatic catheter on day 5, redressed, site cleanNoNo
3Epidural188YesYesNot notedYesRedness day 6 at the insertion site, redressed; no abscess, not infectedNoNo
4Right supraclavicular27, 310YesYesNot notedNot notedThe second catheter had a loose dressing and was removed early on day 3, and the site was clean. YesNo
4Right infraclavicular27, 29YesYesNot notedNot notedThe second catheter had leaked and was removed early; the site was clean.NoNo
5Left popliteal11111YesYesNot notedNot notedNoneNoNo
6Left popliteal211, 920YesYesNot notedNot notedNoneNoNo
6Right popliteal33, 6, 918YesYesNot notedNot notedOne was accidentally removed, one had an unwitnessed disconnect and removed early, and fever for the third.Yes No
7Right femoral43, 15, 2, 323YesYesNot notedNot notedPatient removed NoNo
7Right sciatic43, 7, 13, 528YesYesNot notedNot notedUrine, stool contamination; NoNo
7Right lumbar plexus22, 35YesYesNot notedNot notedLeaking, reinforced, removed early, site cleanNoNo
7Right popliteal 199YesYesYesNot notedUrinated, diarrheaNoNo
8Left supraclavicular 214, 418YesYesYesNot notedNoneYes No, leukocytosis, wound infection
8Right supraclavicular 214, 721YesYesYesNot notedSecond removed by accident early, site cleanYes No
9Left sciatic199YesYesYesNot notedStool contaminationYes No
9Left femoral29, 312YesYesYesNot notedNoneNoNo
9Left popliteal11111YesYesYesNot notedDisconnect/dressing came off, removed, site cleanNoNo
* Antibiotics were completed before the nerve block was removed but were restarted by the surgical and trauma team due to leukocytosis.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Verdecchia, N.; Praslick, A.; Visoiu, M. Safety Assessment of Prolonged Nerve Catheters in Pediatric Trauma Patients: A Case Series Study. Children 2024, 11, 251. https://doi.org/10.3390/children11020251

AMA Style

Verdecchia N, Praslick A, Visoiu M. Safety Assessment of Prolonged Nerve Catheters in Pediatric Trauma Patients: A Case Series Study. Children. 2024; 11(2):251. https://doi.org/10.3390/children11020251

Chicago/Turabian Style

Verdecchia, Nicole, Alexander Praslick, and Mihaela Visoiu. 2024. "Safety Assessment of Prolonged Nerve Catheters in Pediatric Trauma Patients: A Case Series Study" Children 11, no. 2: 251. https://doi.org/10.3390/children11020251

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop